CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Shares withheld for taxes Chief Executive Officer gave up 8,910 shares (to pay taxes)
- 4 Open-market sale Chief Executive Officer sold 10,000 shares at an average $27.44 ($274,416)
- 4 Open-market sale President and CFO sold 36,000 shares at $28.00 ($1,008,000)
- 4 Open-market sale SVP Process Dev, Manufacturing sold 3,000 shares at $25.93 ($77,785)
- 4 Open-market sale President and CFO sold 3,100 shares at an average $25.26 ($78,320)
- 4 Open-market sale Chief Operating Officer sold 2,800 shares at $25.15 ($70,407)
- 4 Open-market sale Chief Executive Officer sold 11,000 shares at an average $25.58 ($281,402)
- 4 Open-market sale VP, Research sold 15,000 shares at an average $25.57 ($383,508)
- 4 Open-market sale SVP Process Dev, Manufacturing sold 3,000 shares at $25.00 ($75,000)
- 4 Open-market sale Chief Executive Officer sold 10,000 shares at an average $23.27 ($232,664)
- 4 Open-market sale SVP Process Dev, Manufacturing sold 3,000 shares at $25.00 ($75,000)
- 4 Open-market sale President and CFO sold 3,100 shares at an average $24.53 ($76,047)
- 4 Open-market sale Chief Executive Officer sold 11,000 shares at an average $24.47 ($269,187)
- 4 Open-market sale President and CFO sold 3,100 shares at $24.00 ($74,400)
- 4 Open-market sale Chief Operating Officer sold 2,800 shares at $22.00 ($61,600)
- 4 Open-market sale Chief Executive Officer sold 10,747 shares at an average $21.00 ($225,696)
- 4 Open-market sale Chief Executive Officer sold 10,253 shares at an average $21.03 ($215,639)
- 4 Grant or award SVP, Gen Counsel & Corp Sec acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 3,125 shares (grant or award)
- 4 Grant or award Director acquired 3,125 shares (grant or award)
Page 14 of 22 · 421 filings